Roivant Sciences Ltd.·4

Apr 1, 7:20 PM ET

Gline Matthew 4

Research Summary

AI-generated summary

Updated

Roivant (ROIV) CEO Matthew Gline Exercises CVARs, Sells Shares

What Happened

  • Matthew Gline (CEO, Director) converted 2,178,150 vested capped value appreciation rights (CVARs) on March 30, 2026; those CVARs were settled into 97,319 common shares. The reported CVAR amount associated with the conversion is $25,048,725 (reported as $11.50 per CVAR in the filing).
  • To satisfy tax withholding obligations, the issuer net-settled/withheld shares: 53,826 shares were withheld on March 30 at $26.41 (value $1,421,545) and 304,684 shares were withheld on March 31 at $27.70 (value $8,439,747). Combined with the CVAR amount, the related reported dispositions/settlements total approximately $34.9 million.
  • These actions were settlements/net-withholdings tied to awards and taxes — not open-market purchases or voluntary block sales.

Key Details

  • Transaction dates & amounts:
    • 2026-03-30: Conversion of 2,178,150 CVARs → 97,319 common shares (CVAR amount reported $25,048,725).
    • 2026-03-30: 53,826 shares withheld @ $26.41 = $1,421,545 (tax withholding).
    • 2026-03-31: 304,684 shares withheld @ $27.70 = $8,439,747 (tax withholding; related to RSUs per footnote).
  • Shares owned after transaction: not specified in the provided excerpt of the filing.
  • Footnotes (simplified):
    • CVARs convert into a cash/stock amount based on excess of fair market value over a hurdle price (F1).
    • The 2,178,150 CVARs satisfied the hurdle and were settled into 97,319 shares using the March 30 closing price (F2).
    • The issuer performed “net settlement” of CVARs and RSUs to cover tax withholding (F3, F4).
    • The CVAR award was fully vested (F5).
  • Filing date: Form 4 filed April 1, 2026 — appears timely relative to the March 30 transaction date.

Context

  • This was an exercise/conversion of derivative awards (CVARs) and subsequent net-share withholding to satisfy taxes — commonly a cashless/net settlement process. These withholdings are routine and do not necessarily signal a discretionary sale for investment purposes.
  • For retail investors: purchases are generally more indicative of bullish insider conviction; these entries primarily reflect compensation settlement and tax withholding rather than an open-market sale.